Scharf Investments, LLC Novartis Ag Transaction History
Scharf Investments, LLC
- $3.36 Billion
- Q3 2025
A detailed history of Scharf Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Scharf Investments, LLC holds 1,210,948 shares of NVS stock, worth $159 Million. This represents 4.62% of its overall portfolio holdings.
Number of Shares
1,210,948
Previous 1,262,444
4.08%
Holding current value
$159 Million
Previous $153 Million
1.65%
% of portfolio
4.62%
Previous 4.72%
Shares
34 transactions
Others Institutions Holding NVS
# of Institutions
1,601Shares Held
137MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...